Promising cholinesterase (acetylcholinesterase and butyrylcholinesterase) inhibitory properties were observed for some of the synthesized compounds (relative to Donepezil, used as the standard reference) that are of potential importance for fighting Alzheimer’s disease (Scheme 68) [99]. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.